Publication:
Cholinergic Urticaria: Clinical Presentation and Natural History in a Tropical Country

dc.contributor.authorChuda Rujitharanawongen_US
dc.contributor.authorPapapit Tuchindaen_US
dc.contributor.authorLeena Chularojanamontrien_US
dc.contributor.authorNattacha Chanchaemsrien_US
dc.contributor.authorKanokvalai Kulthananen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.date.accessioned2020-08-25T09:14:55Z
dc.date.available2020-08-25T09:14:55Z
dc.date.issued2020-01-01en_US
dc.description.abstract© 2020 Chuda Rujitharanawong et al. Background. Cholinergic urticaria (CholU) is a subset of chronic inducible urticaria characterized by the recurrent pinpoint-sized wheals that are induced by exercising or increasing core body temperature. Currently, the data of CholU in tropical climate is still limited. Objective. To investigate the clinical features and natural course of CholU in a tropical country. Materials and Methods. This retrospective chart review study analyzed the data of CholU patients aged over 18 years who visited Siriraj Urticaria Clinic, Siriraj Hospital, Bangkok, Thailand, between January 2007 and September 2019. Demographic data, clinical presentations, and results of provocation tests and other laboratory investigations were evaluated and compared with other studies reported in temperate zones. Results. Sixteen out of 2,175 chronic urticaria patients (0.7%) were diagnosed with CholU. The median age of CholU patients was 28.0±11.7 years with male predominance (56.3%). Three patients (18.8%) had a history of atopy. Fifteen patients (93.8%) were positive to the exercise provocation test. Nonsedating antihistamine drugs were a main treatment (73.8%). Six patients (37.5%) were in remission at the time of the study, with a mean duration 4.3 years. The Kaplan-Meier survival analysis demonstrated that 12.5%, 35.5%, and 67.9% of patients would have disease remission within 1 year, 5 years, and 13 years, respectively. Conclusions. The prevalence of CholU differs in each geographic region and is found to be low in tropical countries with a median duration 4.3 years. The prevalence of atopy and anaphylaxis with CholU is also lower in tropical countries than in temperate.en_US
dc.identifier.citationBioMed Research International. Vol.2020, (2020)en_US
dc.identifier.doi10.1155/2020/7301652en_US
dc.identifier.issn23146141en_US
dc.identifier.issn23146133en_US
dc.identifier.other2-s2.0-85086765942en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/57748
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086765942&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectImmunology and Microbiologyen_US
dc.titleCholinergic Urticaria: Clinical Presentation and Natural History in a Tropical Countryen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086765942&origin=inwarden_US

Files

Collections